These prostate cancer models harbor various alterations in the PI3K pathway and exhibit differential PI3K signaling activity, as shown by the levels of downstream AKT phosphorylation (Fig. 1d, e). The gene discussed is PIK3CD; the disease is prostate carcinoma.